“With high inflows into mid-cap stocks over the last few years, market efficiency within mid-caps have improved a lot. This means that there is less room for active managers to find mispriced stocks and generate alpha,” says Kunal Valia, founder, Statlane, an investment advisory firm.
Divi’s Laboratories shares gain another 5% after Q2 results. Here’s why Jefferies raised target price by 23%
Shares of Divi’s Laboratories jumped 5% following a 64% YoY surge in Q2 FY27 net profit to Rs 1,127 crore. Brokerage Jefferies raised its target